Ciswel 50mg Injection
Marketer
Getwell Pharma (I) Pvt Ltd
Salt Composition
Cisplatin (50mg)
Overview Ciswel 50mg Injection
Oncaspar 50mg Injection, a prescription medication, treats ovarian, cervical, and testicular cancers. Its mechanism involves inhibiting or decelerating cancerous cell proliferation. Administered intravenously by a healthcare professional, dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue use only under medical supervision. Common side effects include injection site inflammation (pain, swelling, redness), nausea, and vomiting. Serious side effects, such as hearing impairment or damage, necessitate pre- and ongoing audiological assessments. The medication can decrease blood cell counts (red and white), increasing infection risk. Regular blood tests monitoring blood cell levels, along with heart, liver, and kidney function, are mandatory. Disclose any history of kidney disease to your doctor prior to treatment, as the medication impacts kidney function. Inform your healthcare provider of all medications you're taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding. Male infertility is a potential side effect; sperm banking should be considered before treatment initiation.
Primary Ingredients of Ciswel 50mg Injection
No text provided. Please provide the text you would like me to rephrase.
Uses of Ciswel 50mg Injection
Cancers affecting the ovaries, cervix, and testes.
Major Benefits of Ciswel 50mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Ciswel 50mg Injection:
- Injection site reactions (pain, swelling, redness)
- Increased risk of infection
- Ear disorder
- Vomiting
- Nausea
- Decreased blood cells (red cells, white cells, and platelets)
- Renal impairment
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Kidney damage
- Hearing loss
- Ringing in ear
How to use Ciswel 50mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Ciswel 50mg Injection works:
Ciswel 50mg Injection is an antineoplastic agent. Its mechanism of action involves disrupting the genetic structure (DNA and RNA) of cancerous cells, thereby inhibiting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ciswel 50mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Ciswel 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Ciswel 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Ciswel 50mg Injection can induce adverse reactions, including drowsiness and nausea, potentially impairing driving ability.
KidneyCAUTION
Individuals with impaired kidney function should use Ciswel 50mg Injection cautiously, potentially requiring dosage modification under medical supervision. Ciswel 50mg Injection is contraindicated in patients exhibiting severe kidney disease.
LiverSAFE IF PRESCRIBED
Ciswel 50mg Injection appears to be well-tolerated by individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Ciswel 50mg Injection :
Omitting a scheduled dose of Ciswel 50mg Injection necessitates contacting your physician.
Facts to Know About Ciswel 50mg Injection
| Label | Value |
|---|---|
| Chemical Category | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Platinum-based Anticancer Agents |


